Gram-positive and Gram-negative bacteria

Gram-positive and Gram-negative bacteria represent the two primary classifications of bacteria based on their cell wall architecture, as determined by the Gram stain technique [StatPearls: Gram Stain]. Gram-positive organisms possess a thick peptidoglycan layer, while Gram-negative organisms feature a thinner peptidoglycan layer and an additional outer membrane containing lipopolysaccharides [StatPearls: Gram Stain; Merck Manual: Overview of Bacteria]. These organisms are the causative agents of numerous infectious diseases, ranging from localized skin infections to life-threatening sepsis [Merck Manual: Overview of Bacteria]. In the context of drug discovery, these are not individual molecular targets but rather complex pathogens containing specific targets such as penicillin-binding proteins, ribosomes, and DNA gyrase [NIH/NIAID: Antimicrobial Resistance]. Antimicrobial drugs are classified by their ability to penetrate these cell walls and inhibit essential bacterial processes [Merck Manual: Overview of Bacteria]. Broad-spectrum antibiotics are designed to be effective against both groups, whereas narrow-spectrum agents target specific bacterial families. The global rise of antimicrobial resistance (AMR) in these groups represents a major therapeutic challenge, as bacteria evolve mechanisms to evade existing drugs [NIH/NIAID: Antimicrobial Resistance]. Effective clinical management often relies on identifying the specific bacterial strain and its susceptibility profile to optimize therapy [StatPearls: Gram Stain]. Understanding the structural differences between these two groups is fundamental to the development of new antibacterial agents.

Other names

BacteriaProkaryotesEubacteriaPathogenic bacteria

Antibacterial agents target these organisms through various mechanisms, including the inhibition of cell wall synthesis (beta-lactams, glycopeptides), inhibition of protein synthesis (macrolides, aminoglycosides, tetracyclines), inhibition of nucleic acid synthesis (fluoroquinolones, rifamycins), and disruption of metabolic pathways (sulfonamides) [StatPearls: Gram Stain; Merck Manual: Overview of Bacteria].